180 likes | 259 Views
Outcome of Spina Bifida in South Wales over a 10 year period 2004- 2013. BINOCAR Scientific meeting 2014 N.Gupta , P.Leach , D.Tucker and J.Calvert Cardiff and Vale University Health Board Congenital Anomaly Register and Information Service in Wales. Background.
E N D
Outcome of Spina Bifida in South Wales over a 10 year period 2004-2013 BINOCAR Scientific meeting 2014 N.Gupta, P.Leach, D.Tucker and J.Calvert Cardiff and Vale University Health Board Congenital Anomaly Register and Information Service in Wales
Background • Spina bifida is a developmental congenital disorder caused by incomplete closure of the embryonic neural tube • The overall prevalence in UK (5.6/10,000 total births) • Rates in Wales higher (up to 7.42/10,000) • Possible genetic predisposition
Aims • The aim of the study was to review the outcomes of pregnancies and babies in whom Spina Bifida was diagnosed and treated at the University Hospital of Wales (UHW) over a 10 year period
Methods • A retrospective audit of all cases of suspected Spina Bifida diagnosed and treated at the University Hospital of Wales from 2004-2013 • Cases were identified using the CARIS database as well as the neonatal and foetal medicine databases • Cases of anencephaly were excluded as well as those not born in South Wales or referred to University Hospital Wales
Results 211 cases identified 203 included in analysis 200 (98.5%) antenatallyDx 3 (1.5%) postnatal Dx 40 (20%) liveborn 156 (76.8%) resulted in TOP 2 (1%) were foetal losses 2 (1%) were still born
Maternal details • Maternal age ranged from 16-43 years • The median age of mothers who continued the pregnancy was 27 years • 32.5% primiparous • The median age of those who terminated the pregnancy was 27 years • 29.4% primiparous
Maternal Folic acid Incomplete data available on 71 cases Folic acid was not taken in 17 (13%) of 132 cases In cases which were livebornfolic acid was not taken in 6 (22%) In the others folic acid was not taken in 11 (10%) of cases One case of suspected foetal valproate syndrome
Antenatal Diagnosis 200 cases suspected antenatally 48 (24%) cases of isolated Spina Bifida Ventriculomegaly seen in 98 (49%) of cases • Additional abnormalities seen in 54 (27%) of cases • These included talipes, hip dislocation, cleft palate, limb, cardiac anomalies, renal and gastro-intestinal anomalies
Chromosomal abnormalities • Chromosomal abnormalities were suspected in diagnosed in 12 cases: • 7 Trisomy(13/18) confirmed, one suspected • 2 confirmed triploidies • One rearrangement of Y chromosome • One case of SaethreChotzen syndrome (deletion in part of chromosome 7)
Outcome • Of the cases of isolated Spina Bifida, 41(85%) resulted in TOP • Of the cases with Spina Bifida and ventriculomegaly 73 (74%) resulted in TOP • Of the cases with additional abnormalities, 42 (78%) resulted in TOP
Postnatal diagnosis • 3 cases were diagnosed post-natally • All isolated • No ventriculomegaly • No additional abnormalities • All 3 required surgery • One of these was a closed lesion
Live births • Of the 43 live births 20(46%) were male and 23(54%) were female • 38(88%) of the defects were open, 5(12%) closed • 19(44%) had ventriculomegaly at birth • 23(53.4%) had additional abnormalities • These included talipes, hip dislocation, cleft palate, limb and cardiac anomalies • Chromosomal anomalies confirmed in 2 cases
Live births • 4 of the live born infants died in the neonatal period. These were related to the severity of the associated hydrocephalus • One baby died during initial resuscitation • 3 had withdrawal of intensive care
Neurosurgery 39 (90.7%) of the live births required closure of the neural tube defect 4(9.3%) did not require surgery Surgery for ventriculomegaly was performed in 20 (46%) of the babies
Summary The congenital anomaly register provides valuable information regarding outcome of pregnancies following diagnosis of suspected anomaly Antenatal diagnosis of Spina Bifida in 98.5% Overall termination of pregnancy in 77% No significant difference in termination rate in presence of additional abnormalities Although folic acid data is incomplete a significant proportion of women did not take folic acid which needs to be addressed
Acknowledgements • Thank you to CARIS for helping providing the Data for the study